Registered entities
Cognito Therapeutics, Inc.
Reg. No. 201-5088United States
Innovation
16 patent families (3 granted) — focus: Human necessities, Electricity & electronics; filing pace accelerating. Cited 1,612 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 10 |
| 2026 | 4 |
Social engagement
Social engagement: 15.5K social following, 7 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Morningside, FoundersX Ventures, IAG Capital Partners, Starbloom.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 58% |
| Private equity | 1 | 8% |
| Other / undisclosed | 4 | 33% |
Hiring activity
Hires occasionally
4 roles tracked across 1 of the last 12 months
24 Jan 2026 · Software Developer · Cambridge
5 Jan 2026 · Manufacturing Engineer · Cambridge
5 Jan 2026 · Quality Engineer · Cambridge
14 Oct 2025 · Software Developer - Contractor · Cambridge
3 Oct 2025 · Executive Assistant to the CEO · Boston
Based on job postings tracked across public sources.
Recent activity
22 Jun 2026
Event
Alzheimers Association® International Conference (AAIC) 2026
20 May 2026
Event
DeviceTalks Boston Fireside Discussion on Alzheimer's treatment and brain health
8 Apr 2026
Partnership
Initiative to Change the D-Word